Intellectual Property
Apr. 28, 2010
Abbott Patent to be Reexamined
A Washington, D.C.-based appeals court wants to take another look at a San Francisco judge's ruling that an Abbott Laboratories patent for technology used in a blood-glucose measuring device is invalid.
Daily Journal Staff Writer
A Washington, D.C.-based appeals court wants to take another look at a San Francisco judge's ruling that an Abbott Laboratories patent for technology used in a blood-glucose measuring device is invalid because an attorney misled a patent office examiner.
The U.S. Court of Appeals for the Federal Circuit decided Monday to vacate U.S. District Judge William Alsup of San Francisco&...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In